Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules.
Journal Information
Full Title: Acta Pharmacol Sin
Abbreviation: Acta Pharmacol Sin
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"We appreciate the grant support from the National Natural Science Foundation of China (82173865, 82130101), Foundation of Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, Chinese Academy of Sciences, Shenzhen Bay Laboratory Open Fund (SZBL2021080601010) and Major Program of Shenzhen Bay Laboratory (S201101001). The support of the Shenzhen Bay supercomputing facility is also acknowledged."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025